Globe Newswire10.11.17
Invuity Inc., a medical technology company focused on minimal access surgery, has announced the reintroduction and full commercial launch of PhotonBlade, a dynamic precision illuminator with enhanced energy. This version of PhotonBlade includes enhancements to improve energy delivery and optimize illumination performance. The company anticipates shipping product to customers in the next few weeks.
PhotonBlade represents a new technology platform for Invuity, delivering directed, thermally cool illumination at the precise point of surgical treatment. PhotonBlade’s energy design consists of a proprietary insulated blade for precise cutting and coagulation of tissue, with minimal effect on adjacent tissue. This sophisticated illumination technology does not require a proprietary generator, thereby leveraging widely available operating room equipment and avoiding an institutional capital investment.
“We are pleased that PhotonBlade has transitioned to full commercial launch and we look forward to providing our clinicians with this technology to better treat their patients,” Invuity CEO Philip Sawyer said. “PhotonBlade exemplifies the company’s strong commitment to providing a broad array of innovative solutions to our customers.”
Invuity Inc. develops and markets advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company's patented Intelligent Photonics technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, Calif.
PhotonBlade represents a new technology platform for Invuity, delivering directed, thermally cool illumination at the precise point of surgical treatment. PhotonBlade’s energy design consists of a proprietary insulated blade for precise cutting and coagulation of tissue, with minimal effect on adjacent tissue. This sophisticated illumination technology does not require a proprietary generator, thereby leveraging widely available operating room equipment and avoiding an institutional capital investment.
“We are pleased that PhotonBlade has transitioned to full commercial launch and we look forward to providing our clinicians with this technology to better treat their patients,” Invuity CEO Philip Sawyer said. “PhotonBlade exemplifies the company’s strong commitment to providing a broad array of innovative solutions to our customers.”
Invuity Inc. develops and markets advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company's patented Intelligent Photonics technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, Calif.